SCHEDULE: Millennium Management Reports Omnicell Stake

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 3.8% of Omnicell, Inc. common stock as of June 30, 2026.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, indicating their beneficial ownership of Omnicell, Inc. common stock.
• As of June 30, 2026, the reporting persons collectively beneficially own 1,734,375 shares of Omnicell, Inc. common stock.
• This represents 3.8% of the class of securities outstanding.
• The filing is an amendment (Amendment No. 1) to a previous filing.
• The reporting persons state that the securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.
• They also certify that the securities were not acquired or held for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without indicating a significant shift in investment strategy or company performance.

Positives

• The filing clarifies the ownership stake of a significant investment management firm, providing transparency to the market.
• The reporting persons certify that their holdings are not intended to influence or change control of Omnicell, Inc., suggesting a passive investment approach.

Negatives

• The filing does not provide any specific financial performance data or forward-looking statements about Omnicell, Inc.

Risks

• The filing does not explicitly mention any risks related to Omnicell, Inc. or the reporting persons' investment strategy.

Future Outlook

No forward-looking statements or specific guidance regarding Omnicell, Inc. are provided in this filing.

Management Comments

• The reporting persons certify that, to the best of their knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in public companies. This filing indicates a notable position by Millennium Management in Omnicell, Inc., a player in the healthcare technology sector, but does not provide insight into the company's operational performance or strategic direction.

Comparison to Industry Standards

• This filing is a standard Schedule 13G disclosure, which is a regulatory requirement for significant beneficial ownership. It does not lend itself to comparison with industry performance benchmarks as it is a disclosure of ownership, not financial results.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which may influence market perception.
• Management of Omnicell, Inc.: The filing confirms that the reporting persons do not intend to influence control, which may be reassuring to current management.

Next Steps

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander will continue to hold their beneficial ownership in Omnicell, Inc. subject to their investment discretion.
• Further filings may be required if their beneficial ownership changes significantly.

Key Dates

Keywords

Omnicell, Millennium Management, Schedule 13G, Beneficial Ownership, Investment Management, Securities, Common Stock, Shareholder